Zusammenfassung
Multiresistente Erreger stellen ein zunehmendes therapeutisches und sozioökonomisches Problem im Gesundheitswesen dar. Zur Eindämmung dieses Problems sind gesundheitspolitische Weichenstellungen, Aufklärung der Öffentlichkeit, Schulung des medizinischen Personals und koordinierte Forschungsanstrengungen erforderlich. Die praktischen Säulen der Prävention von Resistenzentwicklung und -verbreitung ruhen auf dem zielgerichteten, sparsamen Verbrauch von Antibiotika in Human- und Veterinärmedizin, konsequenter Standard-/Basishygiene und allgemeinem Problembewusstsein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
AMB (2007) 41: 57
Backman C, Taylor G, Sales A, Marck PB (2011) An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective. Am J Infect Control 39(5):368–378. doi:10.1016/j.ajic.2010.07.017
BFR (2011) Bundesamt für Risikobewertung: Stellungnahme Nr. 002/2012 vom 5.12.2011
Climo MW, Yokoe DS, Warren DK et al (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542
Cox LA, Popken DA (2014) Quantitative Assessment of Human MRSA RISK from Swine. Risk Anal 34:1639–1650
Daneman N, Sarwar S, Fowler RA, Cuthbertson BH (2013) Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 13:328–41 (on behalf of the SuDDICU Canadian Study Group)
De Smet AMGA, Kluytmans JW, Cooper BS, Mascini EM, Benus RFJ et al (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360:20–31
Derde LP, Cooper BS, Goossens H et al (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14:31–39 (and the MOSAR WP3 Study Team)
Everett BR, Sitton JT, Wilson M (2014) Efficacy and Cost-Benefit Analysis of a Global Environmental Cleaning Algorithm on Hospital-Acquired Infection Rates. J Patient Saf BR Open Access 00:00–00
Fätkenheuer G, Hirschel B, Harbarth S (2015) Screening and isolation to control methicillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. Lancet 385:1146–1149
Fleming A (1929) On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ. Br J Exp Pathol 10(3):226–236
Gastmeier P, Schröder C, Behnke M, Meyer E, Geffers C (2014) Dramatic increase in vancomycin-resistant enterococci in Germany. Antimicrob Chemother 69(6):1660–1664
Harbarth S, Fankhauser C, Schrenzel J et al (2008) Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299:1149–1157
Harris AD, Pineles L, Belton B, Benefits of Universal Glove and Gown (BUGG) Investigators (2013) Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 310:1571–1580
Ho C, Lau A, Cimon K, Farrah K, Gardam M (2012) Screening, Isolation, and Decolonization Strategies for Vancomycin-Resistant Enterococci or Extended Spectrum Beta-Lactamase Producing Organisms: A Systematic Review of the Clinical Evidence and Health Services Impact. Canadian Agency for Drugs and Technologies in Health, Ottawa (Rapid Response Report: Systematic Review)
Houben AJM, Oostdjik EAN, van der Voort PHJ, Monen JCM, Bonten MJM, van der Bij AK (2014) Selective decontamination of the oropharynx and the digestive tract and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother 69:797–804 (on behalf of the ISIS-AR Study Group)
Huang SS, Septimus E, Kleinman K, CDC Prevention Epicenters Program, AHRQ DECIDE Network and Healthcare-Associated Infections Program et al (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265
Huskins WC, Huckabee CM, O’Grady NP, STAR*ICU Trial Investigators (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364:1407–18
Jain R, Kralovic SM, Evans ME et al (2011) Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 364:1419–1130
Kaźmierczak Z, Górski A, Dąbrowska K (2014) Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses 6(7):2551–2570. doi:10.3390/v6072551
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (2014) Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Bundesgesundheitsbl 57:696–732
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (2015) Infektionsprävention im Rahmen der Pflege und Behandlung von Patienten mit übertragbaren Krankheiten. Bundesgesundheitsbl 58:1151–1170
Lee AS, Macedo-Vinas M, François P et al (2011) Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 52:1422–1430
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281
Meyer E, Gastmeier P, Kola A, Schwab F (2012) Pet animals and foreign travel are risk factors for colonisation with extended-spectrum β-lactamase-producing Escherichia coli. Infection 40(6):685–687
Mitchell SL, Shaffer ML, Loeb MB, Givens JL, Habtemariam D et al (2014) Infection Management and Multidrug-Resistant Organisms in Nursing Home Residents With Advanced Dementia. JAMA Intern Med 174:1660–1667. doi:10.1001/jamainternmed.2014.3918.
Morrow LE, Gogineni V, Malesker MA (2012) Probiotics, prebiotic, and synbiotic use in critically ill patients. Curr Opin Crit Care 18:186–191
Oostdijk E, de Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ et al (2010) Ecological effects of selective decontamination on resistant gramnegative bacterial colonisation. Am J Respir Crit Care 181:452–457
Parasion S, Kwiatek M, Gryko R, Mizak L, Malm A (2014) Bacteriophages as an alternative strategy for fighting biofilm development. Pol J Microbiol 63(2):137–145
Petrof EO, Dhaliwal R, Manzanares W, Johnstone J, Cook D, Heyland DK (2012) Probiotics in the critically ill. A systematic review of the randomized trial evidence. Crit Care Med 40:3290–3302
Pogorzelska M, Stone PW, Larson EL (2012) Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections. Am J Infect Control 40(2):96–101. doi:10.1016/j.ajic.2011.10.002
Robicsek A, Beaumont JL, Paule SM et al (2008) Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148:409–418
Sadsad R, Sintchenko V, McDonnell GD, Gilbert GL (2013) Effectiveness of hospital-wide methicillin-resistant Staphylococcus aureus (MRSA) infection control policies differs by ward specialty. PLoS One 8(12):e83099–. doi:10.1371/journal.pone.0083099
Salgado-Pabón W, Schlievert PM (2014) Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol 12(8):585–591. doi:10.1038/nrmicro3308
Schulz-Stübner S (2013) From SDD to a risk- and CIRCOdiagnosis-based approach for treatment and prophylaxis of intestinal bacterial overgrowth in critically ill patients. Intensive Care Med 39:973–974
Schulz-Stübner S (2014) Berufsgruppenspezifisches Vorbildverhalten in Sachen Hygiene. Krankenhaushygiene up2date 9:173–184
Silvestri L, De la Cal M, Van Saene HKF (2012) Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intensive Care Med 38:1738–1750
TRBA 250 (2014) Technische Regeln Biologische Arbeitsstoffe: Biologische Arbeitsstoffe im Gesundheitswesen und in der Wohlfahrtspflege. Ausgabe März 2014 GMBl 2014, Nr. 10/11 vom 27.03.2014 Änderung vom 22.05.2014, GMBl Nr. 25
Tübbicke A, Hübner C, Hübner NO, Wegner C, Kramer A, Fleßa S (2013) Cost comparison of MRSA screening and management – a decision tree analysis. BMC Health Services Research 12:438
Zahar JR 1, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, Ara-Somohano C, Misset B, Timsit JF (2013) In Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med 39(12):2153–2160
Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clark L, Allegranzi B, Magiorakos AP, Pittet D (2015) Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis 15(2):212–224 (for the systematic review and evidence-based guidance on organization of hospital infection control programmes (SIGHT) study group)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schulz-Stübner, S. (2016). Geschichtliche Entwicklung und Public-Health-Aspekte. In: Schulz-Stübner, S., Dettenkofer, M., Mattner, F., Meyer, E., Mahlberg, R. (eds) Multiresistente Erreger. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48069-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-48069-4_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48068-7
Online ISBN: 978-3-662-48069-4
eBook Packages: Medicine (German Language)